Archives
- 2018-07
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
- 2025-09
-
2'3'-cGAMP (Sodium Salt): Expanding the Frontiers of STIN...
2025-09-26
Explore the advanced roles of 2'3'-cGAMP (sodium salt) in STING-mediated innate immune response, focusing on its molecular mechanisms and applications in immunotherapy research. This article uniquely dissects translational and methodological innovations beyond vascular normalization.
-
S63845: Precision MCL1 Inhibition for Functional Apoptosi...
2025-09-25
Discover how S63845, a potent MCL1 inhibitor, uniquely enables high-resolution functional profiling of mitochondrial apoptosis in cancer research. This article explores S63845’s mechanistic depth, advanced combinatorial strategies, and its differentiation as a tool for dissecting BCL-2 family–regulated cell death.
-
AZD0156: Advancing ATM Kinase Inhibition for Synthetic Le...
2025-09-24
Discover how AZD0156, a potent ATM kinase inhibitor, enables synthetic lethality strategies and precision targeting of DNA damage response pathways in cancer research. This in-depth analysis explores mechanistic insights, emerging vulnerabilities, and practical considerations distinct from prior content.
-
2'3'-cGAMP (sodium salt): Mechanistic Insights into Endot...
2025-09-23
Explore the mechanistic role of 2'3'-cGAMP (sodium salt) in orchestrating endothelial STING-mediated innate immune responses, with emphasis on its impact for cancer immunotherapy and vascular normalization. This article provides novel perspectives for research leveraging this potent STING agonist.
-
Berberine (CAS 2086-83-1): Bridging AMPK Activation and I...
2025-09-22
This article explores the multifaceted role of Berberine (CAS 2086-83-1) as an isoquinoline alkaloid, highlighting its unique capacity as an AMPK activator for metabolic regulation and its emerging relevance in inflammation pathways, particularly in the context of inflammasome research. The discussion integrates recent mechanistic insights and provides practical guidance for metabolic disease and i
-
Advanced Applications of EZ Cap™ EGFP mRNA (5-moUTP) in m...
2025-09-19
Explore the unique capabilities of EZ Cap™ EGFP mRNA (5-moUTP) for enhancing mRNA stability and suppressing innate immune activation in translational research. This article examines the interplay of capped mRNA with Cap 1 structure, 5-moUTP incorporation, and poly(A) tail engineering for robust gene expression and advanced in vivo imaging.
-
ABT-737 and the Mitochondrial Apoptosis Pathway: A Tool f...
2025-09-18
Explore how ABT-737, a potent BH3 mimetic and BCL-2 protein inhibitor, advances mechanistic studies of apoptosis induction in cancer cells. This article highlights novel intersections with recent findings on mitochondria-mediated cell death signaling.
-
AKT has been shown to be
2025-03-03
AKT1 has been shown to be important for G1-S checkpoint transition and proliferation, whereas AKT2 regulates cell-cycle exit through its interaction with p21 (Héron-Milhavet et al., 2006). In a recent study in triple negative breast cancer, AKT3, rather than AKT1 activity was most important for cell
-
Nrf br AhR br Nrf and
2025-03-03
Nrf2 AhR Nrf2 and AhR: friends or foes for energetic metabolism? Perspectives in carcinogenesis upon xenobiotic exposure Acknowledgements Introduction Integration of endogenous and exogenous signals via appropriate receptors is at the core of biological differentiation and adaptive r
-
hydroxydopamine OHDA is a selective catecholaminergic neurot
2025-03-03
6-hydroxydopamine (6-OHDA) is a selective catecholaminergic neurotoxin mainly used to generate lesions in the nigrostriatal pathway in rats (Ungerstedt, 1968). The most common use of 6-OHDA is via unilateral injection into the rat medial forebrain bundle (MFB). DA depletion, nigral DA cell loss, and
-
Demethoxycurcumin The central problem in amnesia developing
2025-03-03
The central problem in amnesia developing following impairment of long-term memory consolidation or reconsolidation is a question of the underlying mechanisms, whether it is caused by impairment of retrieval or memory storage mechanisms [3,8,9,[15], [16], [17], [18]]. To answer this question, severa
-
In order to increase the oral
2025-03-03
In order to increase the oral bioavailability, abiraterone (157) is being used in the form of its 3β-acetoxy prodrug, abiraterone acetate (156). In spite of the fact that high-fat meals increase the oral GW 6471 australia of abiraterone acetate (156), it is recommended that this drug should be take
-
Our research is the first
2025-03-01
Our research is the first to report that administration of HMW-HA is an effective strategy to defend against PM2.5-induced disruption of pulmonary epithelial barrier and lung injury, and addresses that HMW-HA restricts PM2.5-induced epithelial apoptosis through reducing oxidative stress and followin
-
br Results br Discussion ER and GR play opposite
2025-03-01
Results Discussion ER and GR play opposite phenotypic roles in the normal endometrium, with ER promoting growth and GR inhibiting growth. Here, we show that in endometrial cancer, GR expression is associated with worse outcomes and higher-grade tumors, and this association is observed only in
-
FSLLRY-NH2 br Material and methods br Results br Discussion
2025-03-01
Material and methods Results Discussion This study explores the hypothesis that ASK1, via transcriptional upregulation by E2F1, molecularly defines AT that supports a dys-metabolic obese phenotype in humans. We demonstrate associations between increased visceral-AT ASK1 expression and multi